Sensory Deficit Following ACL Reconstruction: PRF Pilot Study
PRF-ACL
The Effect of Platelet-rich Fibrin on the Regeneration of Patellar Ligament Defects and the Functional Recovery of Patients After Anterior Cruciate Ligament Reconstruction of the Knee
2 other identifiers
observational
53
1 country
1
Brief Summary
Pilot, single-center, non-randomized, parallel-group clinical study designed to assess whether intraoperative application of autologous platelet-rich fibrin (PRF) at the bone-patellar tendon-bone (BPTB) donor site reduces postoperative anterior knee sensory deficit after anterior cruciate ligament (ACL) reconstruction in competitively active male athletes. Planned enrollment is 53 participants allocated to a PRF cohort or a standard-care cohort. The primary outcome is the proportion of participants without anterior knee sensory deficit at 12 months post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2025
CompletedFirst Submitted
Initial submission to the registry
September 23, 2025
CompletedFirst Posted
Study publicly available on registry
December 2, 2025
CompletedDecember 15, 2025
December 1, 2025
1 year
September 23, 2025
December 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of participants without anterior knee sensory deficit at the donor site
Sensory function assessed over a predefined 9-point area lateral to the surgical scar; deficit coded as 1 if \>3 points are reported as "no or altered touch," otherwise 0. Assessment performed with eyes closed; contralateral knee used for reference if uncertain. Measure Type \& Units: Percentage of participants (%)
12 months post-surgery
Secondary Outcomes (1)
International Knee Documentation Committee (IKDC) Subjective Knee Form score (0-100; higher scores indicate better function)
Baseline, 4, 8, and 12 months post-surgery
Other Outcomes (1)
Lysholm Knee Scoring Scale (0-100; higher scores indicate better function)
Baseline, 4, 8, 12 months after surgery
Study Arms (2)
PRF Group
Patients undergoing ACL reconstruction with a bone-patellar tendon-bone (BPTB) autograft, with platelet-rich fibrin (PRF) applied at the donor site (n=24)
Control Group
Patients undergoing ACL reconstruction with a BPTB autograft, treated with standard closure without PRF (n=29)
Interventions
Autologous PRF prepared intraoperatively from patient's venous blood and applied at the donor site after graft harvesting.
Conventional closure of the donor site without PRF application
Eligibility Criteria
Patients undergoing ACL reconstruction with bone-patellar tendon-bone (BPTB) autograft at the University Clinical Center of Serbia
You may qualify if:
- Age 18-40 years
- Isolated anterior cruciate ligament rupture confirmed by MRI and clinical examination
- Planned ACL reconstruction with BPTB autograft
- Written informed consent provided
You may not qualify if:
- Previous knee surgery on the affected knee
- Associated ligament injuries requiring additional reconstruction
- Significant cartilage damage (Outerbridge grade III-IV beyond donor site changes)
- Systemic disease affecting wound healing (e.g., diabetes mellitus, autoimmune disease)
- Active infection
- Refusal or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinical Center of Serbia (UKCS)
Belgrade, 11000, Serbia
Related Publications (2)
Shichman I, Baruchi D, Rachevsky G, Amzallag N, Brandstetter AS, Vidra M, Morag G. Bone filling decreases donor site morbidity after anterior cruciate ligament reconstruction with bone-patellar tendon-bone autografts. Arch Orthop Trauma Surg. 2023 May;143(5):2565-2572. doi: 10.1007/s00402-022-04572-5. Epub 2022 Aug 2.
PMID: 35916963BACKGROUNDMilovanovic D, Kadija M, Gavrilovic D, Sreckovic S, Bilanovic M, Matic A, Vukman P. Sensory Deficit Following Anterior Cruciate Ligament Reconstruction with Bone-Patellar Tendon-Bone Autograft: Platelet-Rich Fibrin (PRF) Could Provide a Solution. Medicina (Kaunas). 2025 Dec 12;61(12):2202. doi: 10.3390/medicina61122202.
PMID: 41470204DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, University Clinical Center of Serbia, Docent, Faculty of Medicine, University of Belgrade
Study Record Dates
First Submitted
September 23, 2025
First Posted
December 2, 2025
Study Start
January 7, 2022
Primary Completion
January 7, 2023
Study Completion
July 14, 2025
Last Updated
December 15, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy considerations and institutional regulations. Summary results will be published in peer-reviewed journals.